atractylenolide iii has been researched along with Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, J; Ke, X; Liu, T; Lu, H; Ma, J; Tan, S; Wang, S | 1 |
1 other study(ies) available for atractylenolide iii and Breast Neoplasms
Article | Year |
---|---|
The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Lactones; Mice; Neoplasm Metastasis; Sesquiterpenes; Signal Transduction; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2016 |